222
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Origins of fibroblasts in rheumatoid synovial tissues: Implications from organ fibrotic models

, , &
Pages 579-582 | Received 23 Jun 2017, Accepted 22 Sep 2017, Published online: 25 Oct 2017
 

Abstract

Fibroblasts play crucial roles in the pathogenesis of rheumatoid arthritis (RA). Accumulation of fibroblasts in the synovial tissues characterizes the pathology of RA. Understanding how fibroblasts accumulate could lead to discovery of new therapeutic targets in RA treatment, while current antirheumatic therapies still have problems in efficacy and safety. In this regard, several studies have revealed cellular origins of fibroblasts in fibrotic tissues in murine models of organ fibrosis. Some studies employed lineage tracing, which bring generally convincing results, using transgenic mice. They demonstrated that resident fibroblasts, pericytes, mesenchymal stem cells, epithelial cells, endothelial cells and bone-marrow-derived and circulating cells can be cellular origins of fibroblasts in organ fibrotic tissues. In this review, we summarize and discuss available evidence for the origins of fibroblasts accumulating in the arthritic synovial tissues and organ fibrotic tissues.

Conflict of interest

Hitoshi Kohsaka received consulting fees and/or speaking fees from Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., and Teijin Pharma Limited. H.K. also received research grants from Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Astellas Pharma Inc., Novartis Pharma K.K., Takeda Pharmaceutical Company Limited., Eisai Co., Ltd., Pfizer Japan Inc., Chugai Pharmaceutical Co., Ltd., Teijin Pharma Limited, Ayumi Pharmaceutical Corporation, AbbVie GK, Japan Blood Products Organization, Eli Lilly Japan K.K., and Asahi Kasei Pharma Corporation. Yusuke Matsuo received speaking fees from Pfizer Japan Inc. Tetsuya Saito and Akio Yamamoto have no conflict of interest to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.